Archive: 28/06/2018

CAR-T immunotherapies may have a new player

Emerging CAR-T immunotherapies leverage modified versions of patient's T-cells to target and kill cancer cells. In a new study, published June 28 online in Cell Stem Cell, researchers at University of California San Diego ...

Jun 28, 2018
popularity33 comments 0